Head and Neck Cancer Registry (LORHAN)

Lilly

Status: Completed

Conditions: Head and Neck Cancer

Treatments: Other: Therapy for head and neck cancer

Study type: Observational

Funder types: Industry

Identifiers

NCT01080313

13440

I4E-US-S003 (Other Identifier)

Details and patient eligibility

About

The primary objective of this study is to describe, in detail, patterns of care for head and neck carcinoma patient

Enrollment: 26,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Pathologically (histologically or cytologically) confirmed new diagnosis of carcinoma involving the oral cavity, oropharynx, nasopharynx, hypopharynx, larynx, or neck node metastasis from unknown origin
• Scheduled to receive radiotherapy and/or drug therapy including chemotherapy, biologic therapy and targeted therapy
• Written informed consent

Exclusion criteria

• Registry participation does not exclude participation in clinical trials.
• Patients scheduled to receive or who have received surgery are eligible for Registry participation as long as they are also scheduled to receive medical therapy.

Trial design

26,000 participants in 1 patient group

Patients with head and neck cancer

Treatment:

Other: Therapy for head and neck cancer